vs
Side-by-side financial comparison of GLADSTONE COMMERCIAL CORP (GOOD) and STEM, INC. (STEM). Click either name above to swap in a different company.
STEM, INC. is the larger business by last-quarter revenue ($47.1M vs $43.5M, roughly 1.1× GLADSTONE COMMERCIAL CORP). GLADSTONE COMMERCIAL CORP runs the higher net margin — 12.4% vs -33.9%, a 46.3% gap on every dollar of revenue. On growth, GLADSTONE COMMERCIAL CORP posted the faster year-over-year revenue change (16.3% vs -15.6%). Over the past eight quarters, STEM, INC.'s revenue compounded faster (36.1% CAGR vs 10.3%).
Gladstone Commercial Corp is a publicly traded US real estate investment trust focused on acquiring, owning, and operating diversified industrial and commercial properties. It offers long-term net lease agreements to tenants across manufacturing, logistics, healthcare and professional services sectors, mainly serving small to mid-sized business clients.
StemCells, Inc. is a public biopharmaceutical company headquartered in Newark, California, that is developing purified human neural stem cells (HuCNS-SCs) in the hopes of treating central nervous system disorders and paralysis. StemCells' HuCNS-SCs have the ability to differentiate into the three main types of cells found in the central nervous system: neurons, astrocytes and oligodendrocytes.
GOOD vs STEM — Head-to-Head
Income Statement — Q4 FY2025 vs Q4 FY2025
| Metric | | |
|---|---|---|
| Revenue | $43.5M | $47.1M |
| Net Profit | $5.4M | $-16.0M |
| Gross Margin | — | 48.9% |
| Operating Margin | — | -17.7% |
| Net Margin | 12.4% | -33.9% |
| Revenue YoY | 16.3% | -15.6% |
| Net Profit YoY | -25.1% | 68.8% |
| EPS (diluted) | $0.05 | $-4.40 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q4 25 | $43.5M | $47.1M | ||
| Q3 25 | $40.8M | $38.2M | ||
| Q2 25 | $39.5M | $38.4M | ||
| Q1 25 | $37.5M | $32.5M | ||
| Q4 24 | $37.4M | $55.8M | ||
| Q3 24 | $39.2M | $29.3M | ||
| Q2 24 | $37.1M | $34.0M | ||
| Q1 24 | $35.7M | $25.5M |
| Q4 25 | $5.4M | $-16.0M | ||
| Q3 25 | $4.1M | $-23.8M | ||
| Q2 25 | $4.6M | $202.5M | ||
| Q1 25 | $5.1M | $-25.0M | ||
| Q4 24 | $7.2M | $-51.1M | ||
| Q3 24 | $11.7M | $-148.3M | ||
| Q2 24 | $1.6M | $-582.3M | ||
| Q1 24 | $3.5M | $-72.3M |
| Q4 25 | — | 48.9% | ||
| Q3 25 | — | 35.5% | ||
| Q2 25 | — | 33.4% | ||
| Q1 25 | — | 32.4% | ||
| Q4 24 | — | -4.4% | ||
| Q3 24 | — | 21.2% | ||
| Q2 24 | — | 27.6% | ||
| Q1 24 | — | -95.0% |
| Q4 25 | — | -17.7% | ||
| Q3 25 | — | -33.6% | ||
| Q2 25 | — | -34.8% | ||
| Q1 25 | — | -65.0% | ||
| Q4 24 | — | -84.4% | ||
| Q3 24 | — | -493.2% | ||
| Q2 24 | — | -1705.5% | ||
| Q1 24 | — | -267.0% |
| Q4 25 | 12.4% | -33.9% | ||
| Q3 25 | 10.1% | -62.2% | ||
| Q2 25 | 11.7% | 527.8% | ||
| Q1 25 | 13.7% | -76.9% | ||
| Q4 24 | 19.2% | -91.6% | ||
| Q3 24 | 29.8% | -506.3% | ||
| Q2 24 | 4.3% | -1712.6% | ||
| Q1 24 | 9.9% | -283.9% |
| Q4 25 | $0.05 | $-4.40 | ||
| Q3 25 | $0.02 | $-2.84 | ||
| Q2 25 | $0.03 | $-1.79 | ||
| Q1 25 | $0.04 | $-0.15 | ||
| Q4 24 | $0.10 | $-15.29 | ||
| Q3 24 | $0.20 | $-18.24 | ||
| Q2 24 | $-0.04 | $-71.81 | ||
| Q1 24 | $0.01 | $-0.46 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $10.8M | $48.9M |
| Total DebtLower is stronger | $843.5M | — |
| Stockholders' EquityBook value | $171.8M | $-249.4M |
| Total Assets | $1.2B | $308.9M |
| Debt / EquityLower = less leverage | 4.91× | — |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $10.8M | $48.9M | ||
| Q3 25 | $18.4M | $43.1M | ||
| Q2 25 | $11.7M | $40.8M | ||
| Q1 25 | $10.4M | $58.6M | ||
| Q4 24 | $11.0M | $56.3M | ||
| Q3 24 | $10.5M | $75.4M | ||
| Q2 24 | $10.4M | $89.6M | ||
| Q1 24 | $10.5M | $112.8M |
| Q4 25 | $843.5M | — | ||
| Q3 25 | $843.3M | — | ||
| Q2 25 | $794.4M | — | ||
| Q1 25 | $740.7M | — | ||
| Q4 24 | $693.4M | — | ||
| Q3 24 | $692.6M | — | ||
| Q2 24 | $722.5M | — | ||
| Q1 24 | $719.4M | — |
| Q4 25 | $171.8M | $-249.4M | ||
| Q3 25 | $184.8M | $-235.7M | ||
| Q2 25 | $177.2M | $-214.1M | ||
| Q1 25 | $183.2M | $-417.5M | ||
| Q4 24 | $171.2M | $-398.4M | ||
| Q3 24 | $168.9M | $-344.1M | ||
| Q2 24 | $145.7M | $-203.2M | ||
| Q1 24 | $147.3M | $371.6M |
| Q4 25 | $1.2B | $308.9M | ||
| Q3 25 | $1.3B | $362.6M | ||
| Q2 25 | $1.2B | $379.2M | ||
| Q1 25 | $1.2B | $405.1M | ||
| Q4 24 | $1.1B | $437.4M | ||
| Q3 24 | $1.1B | $537.8M | ||
| Q2 24 | $1.1B | $691.5M | ||
| Q1 24 | $1.1B | $1.3B |
| Q4 25 | 4.91× | — | ||
| Q3 25 | 4.56× | — | ||
| Q2 25 | 4.48× | — | ||
| Q1 25 | 4.04× | — | ||
| Q4 24 | 4.05× | — | ||
| Q3 24 | 4.10× | — | ||
| Q2 24 | 4.96× | — | ||
| Q1 24 | 4.88× | — |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | $88.2M | $8.2M |
| Free Cash FlowOCF − Capex | — | — |
| FCF MarginFCF / Revenue | — | — |
| Capex IntensityCapex / Revenue | — | — |
| Cash ConversionOCF / Net Profit | 16.38× | — |
| TTM Free Cash FlowTrailing 4 quarters | — | — |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $88.2M | $8.2M | ||
| Q3 25 | $18.9M | $11.4M | ||
| Q2 25 | $35.8M | $-21.3M | ||
| Q1 25 | $17.7M | $8.5M | ||
| Q4 24 | $57.0M | $-14.7M | ||
| Q3 24 | $5.5M | $-9.4M | ||
| Q2 24 | $13.6M | $-11.9M | ||
| Q1 24 | $15.0M | $-621.0K |
| Q4 25 | 16.38× | — | ||
| Q3 25 | 4.57× | — | ||
| Q2 25 | 7.74× | -0.11× | ||
| Q1 25 | 3.44× | — | ||
| Q4 24 | 7.93× | — | ||
| Q3 24 | 0.47× | — | ||
| Q2 24 | 8.44× | — | ||
| Q1 24 | 4.26× | — |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
